Leu-enkefalin

Leu-enkefalin
Nazivi
	IUPAC nazivs (2R)-2-[[(2R)-2-[[2-[[2-[[(2R)-2-amino-3-; (4-hydroxyphenyl)propanoyl]amino]acetyl]; amino]acetyl]amino]-3-phenylpropanoyl]; amino]-4-methylpentanoic acid
Identifikacija
CAS broj	58822-25-6;
3D model (Jmol)	interaktivna slika;
ChemSpider	21106451;
ECHA InfoCard	100.055.852
IUPHAR/BPS	1613;
PubChem C ID	10415290;
	SMILES Oc2ccc(C[C@H](N)C(=O)NCC(=O)NCC(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(O)=O)cc2; ; ; ; ; ;
Svojstva
Hemijska formula	C28H37N5O7
Molarna masa	555,62268 g/mol
	Ukoliko nije drugačije napomenuto, podaci se odnose na standardno stanje materijala (na 25 °C [77 °F], 100 kPa).
	Reference infokutije

Leu-enkefalin je endogenni opioidni peptidni neurotransmiter koji se prirodno javlja u mozgu mnogih životinja, uključujući čoveka.^[3]^[4] On je jedna od dve forme enkefalina. Druga forma je met-enkefalin. Za tirozinski ostatak u poziciji 1 se smatra da je analogan sa 3-hidroksilnom grupom morfina.

Leu-enkefalin je peptid sa sekvencom: Tyr - Gly - Gly - Phe - Leu. On proizvodi farmakološke efekte na mi i delta opioidnim receptorima, mada ima veću potentnost na delta receptoru.

^ Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today. 15 (23-24): 1052—7. PMID 20970519. doi:10.1016/j.drudis.2010.10.003. уреди
^ Evan E. Bolton; Yanli Wang; Paul A. Thiessen; Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry. 4: 217—241. doi:10.1016/S1574-1400(08)00012-1.
^ Dudás B, Merchenthaler I (2003 Apr). „Topography and associations of leu-enkephalin and luteinizing hormone-releasing hormone neuronal systems in the human diencephalon”. J Clin Endocrinol Metab. 88 (4): 1842—8. Проверите вредност парамет(а)ра за датум: |date= (помоћ)
^ {{|title=Immunocytochemical studies with antisera against Leu-enkephalin and an enkephalin-precursor fragment (BAM-22P) in the rat brain |author=Khachaturian, Henry Lewis, Michael E. Watson, Stanley J. |year=2006 |publisher = Elsevier |doi=10.1016/0024-3205(82)90233-8 |pmid=6759829 |url=http://hdl.handle.net/2027.42/23839}}

[1] Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today. 15 (23-24): 1052—7. PMID 20970519. doi:10.1016/j.drudis.2010.10.003. уреди

[2] Evan E. Bolton; Yanli Wang; Paul A. Thiessen; Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry. 4: 217—241. doi:10.1016/S1574-1400(08)00012-1.

[3] Dudás B, Merchenthaler I (2003 Apr). „Topography and associations of leu-enkephalin and luteinizing hormone-releasing hormone neuronal systems in the human diencephalon”. J Clin Endocrinol Metab. 88 (4): 1842—8. Проверите вредност парамет(а)ра за датум: |date= (помоћ)

[4] {{|title=Immunocytochemical studies with antisera against Leu-enkephalin and an enkephalin-precursor fragment (BAM-22P) in the rat brain |author=Khachaturian, Henry Lewis, Michael E. Watson, Stanley J. |year=2006 |publisher = Elsevier |doi=10.1016/0024-3205(82)90233-8 |pmid=6759829 |url=http://hdl.handle.net/2027.42/23839}}

[1]

[2]

[3]

[4]